Click Here to return To Results

 

In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic Neurologist 27:290-297, Gritsch, D.,et al, 2022 See this aricle in Pubmed Article Abstract Co-administration of ipilimumab and nivolumab as first line therapy is effective in the treatment of asymptomatic melanoma brain metastases, with an acceptable safety profile.

Related Tags

(click to filter results - removes previous filter) efficacy immune checkpoint inhibitors melanoma,malignant neoplasm,metastatic to CNS neoplasm,metastatic to CNS-treatment of review article safety treatment of neurologic disorder

Click Here to return To Results